KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

编者按原发性膜性肾病（PMN）的治疗策略是肾脏病学领域的关键议题，其围绕优化抗蛋白尿治疗及一线干预措施展开，而抗 M 型磷脂酶 A2 受体（PLA2R）抗体检测在其中扮演着核心角色，深刻影响着诊疗决策。尽管已有相关指南，如Kidney Disease: Improving Global Outcomes（KDIGO）2021 ...

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

This represented 440,749 individuals who met Kidney Disease Improving Global Outcomes (KDIGO) clinical CKD criteria, ...